Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing

The close monitoring of HIV drug resistance using genotypic HIV drug resistance testing (HIVDRT) has become essential for effective HIV/AIDS management at both individual and population levels. Over the years, a broad spectrum of analytes or specimens have been applied or attempted in HIVDRT; howeve...

Full description

Bibliographic Details
Main Authors: Hezhao Ji, Paul Sandstrom
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/7/739
_version_ 1797433238876061696
author Hezhao Ji
Paul Sandstrom
author_facet Hezhao Ji
Paul Sandstrom
author_sort Hezhao Ji
collection DOAJ
description The close monitoring of HIV drug resistance using genotypic HIV drug resistance testing (HIVDRT) has become essential for effective HIV/AIDS management at both individual and population levels. Over the years, a broad spectrum of analytes or specimens have been applied or attempted in HIVDRT; however, the suitability and performance of these analytes in HIVDRT and the clinical relevance of the results from them may vary significantly. This article provides a focused overview of the performance, strengths, and weaknesses of various analytes while used in HIVDRT, which may inform the optimal analytes selection in different application contexts.
first_indexed 2024-03-09T10:13:13Z
format Article
id doaj.art-34d7cafe5e7a4a6d918aa051b3a270ef
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T10:13:13Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-34d7cafe5e7a4a6d918aa051b3a270ef2023-12-01T22:32:33ZengMDPI AGPathogens2076-08172022-06-0111773910.3390/pathogens11070739Overview of the Analytes Applied in Genotypic HIV Drug Resistance TestingHezhao Ji0Paul Sandstrom1National Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, CanadaNational Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, CanadaThe close monitoring of HIV drug resistance using genotypic HIV drug resistance testing (HIVDRT) has become essential for effective HIV/AIDS management at both individual and population levels. Over the years, a broad spectrum of analytes or specimens have been applied or attempted in HIVDRT; however, the suitability and performance of these analytes in HIVDRT and the clinical relevance of the results from them may vary significantly. This article provides a focused overview of the performance, strengths, and weaknesses of various analytes while used in HIVDRT, which may inform the optimal analytes selection in different application contexts.https://www.mdpi.com/2076-0817/11/7/739HIVdrug resistancetestinganalytesspecimensperformance
spellingShingle Hezhao Ji
Paul Sandstrom
Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
Pathogens
HIV
drug resistance
testing
analytes
specimens
performance
title Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
title_full Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
title_fullStr Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
title_full_unstemmed Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
title_short Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
title_sort overview of the analytes applied in genotypic hiv drug resistance testing
topic HIV
drug resistance
testing
analytes
specimens
performance
url https://www.mdpi.com/2076-0817/11/7/739
work_keys_str_mv AT hezhaoji overviewoftheanalytesappliedingenotypichivdrugresistancetesting
AT paulsandstrom overviewoftheanalytesappliedingenotypichivdrugresistancetesting